FDA Investigator: Debra M. Emerson

- Debra M. Emerson first started conducting FDA inspections in 2002, with the last inspection in 2022. Over that time, Debra M. Emerson has conducted 228 inspections at 180 companies across 191 sites.

Get Debra Emerson's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 ID Biomedical Corporation of Quebec, Quebec | 2022

Out-of-stock
Debra M. Emerson
Biologic Form 483

FDA 483 Emergent BioSolutions Canada Inc., Winnipeg | 2022

Out-of-stock
Debra M. Emerson
Biologic Form 483

FDA 483 LFB USA, Inc., Charlton | 2022

Out-of-stock
Debra M. Emerson
Biologic Form 483

FDA 483 CSL Behring GmbH, Marburg | 2022

Out-of-stock
Debra M. Emerson
Biologic Form 483

FDA 483 Catalent Maryland, Inc., Harmans | 2021

Out-of-stock
Debra M. Emerson
Biologic Form 483

FDA 483 Lonza Biologics, Inc., Portsmouth | 2021

Out-of-stock
Debra M. Emerson
Biologic Form 483

FDA 483 Therapure Biopharma Inc, Mississauga | 2020

Out-of-stock
Debra M. Emerson
Biologic Form 483

FDA 483 Rentschler Biopharma Inc., Milford | 2019

Out-of-stock
Debra M. Emerson
Biologic Form 483

FDA 483 MassBiologics, Boston | 2019

Out-of-stock
Debra M. Emerson
Biologic Form 483

FDA 483 Glaxosmithkline, Wavre | 2019

Out-of-stock
Debra M. Emerson
Biologic Form 483

FDA 483 GlaxoSmithKline Biologicals SA, Rixensart | 2019

Out-of-stock
Debra M. Emerson
Biologic Form 483

FDA 483 Charles River Laboratories, Inc. DBA Charles River, Endosafe, Charleston | 2019

Out-of-stock
Debra M. Emerson
Biologic Form 483

FDA 483 Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna | 2019

Out-of-stock
Debra M. Emerson
Biologic Form 483

Co-Investigators (84)